drugset / Trial / NCT04834531

Effect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng)

NCT04834531 ↗

Phase 4 Unknown 324 enrolled Zhong Wang
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial aims to evaluate the clinical control rate of sputum by Zhuli Capsule in the treatment of the Phlegm-heat Syndrome (Tan-re Zheng)in the patients with acute exacerbation of chronic obstructive pulmonary disease or chronic bronchitis.

Timeline

Start
2021-07
Primary completion
2023-10
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Zhuli capsule Unknown 1.2 g Oral

Indications